NASDAQ:CLGN - COLLPLANT HOLDI/S Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $5.60 -0.15 (-2.61 %) (As of 02/22/2019 04:00 PM ET)Previous Close$5.60Today's Range$5.60 - $5.7052-Week Range$3.13 - $8.73Volume460 shsAverage Volume7,034 shsMarket Capitalization$19.15 millionP/E Ratio-2.48Dividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsInstitutional OwnershipHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email CollPlant Holdings Ltd., a regenerative medicine company, focuses on developing and commercializing tissue repair products for three-dimensional (3D) bio-printing of tissues and organs, orthobiologics, and advanced wound care markets in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen (rhCollagen) that is produced with its proprietary plant based genetic engineering technology. The company's products include Vergenix STR, a soft tissue repair matrix intended for treatment of tendinopathy; Vergenix FG, a wound-filling flowable gel for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; and BioInks for 3D printing of tissues and organs. CollPlant Holdings Ltd. has a license, development, and commercialization agreement with United Therapeutics Corporation for 3D bioprinting of solid-organ scaffolds for human transplants. The company is headquartered in Ness Ziona, Israel. Receive CLGN News and Ratings via Email Sign-up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CLGN Previous Symbol CUSIPN/A CIKN/A Webwww.collplant.com Phone972-73-232-5600Debt Debt-to-Equity Ratio0.01 Current Ratio3.93 Quick Ratio3.17Price-To-Earnings Trailing P/E Ratio-2.48 Forward P/E Ratio-10.00 P/E GrowthN/A Sales & Book Value Annual Sales$480,000.00 Price / Sales39.90 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)($2.26) Net Income$-6,020,000.00 Net Margins-435.47% Return on Equity-74.04% Return on Assets-39.88%Miscellaneous Employees29 Outstanding Shares3,420,000Market Cap$19.15 million Next Earnings Date3/20/2019 (Estimated) OptionableNot Optionable COLLPLANT HOLDI/S (NASDAQ:CLGN) Frequently Asked Questions What is COLLPLANT HOLDI/S's stock symbol? COLLPLANT HOLDI/S trades on the NASDAQ under the ticker symbol "CLGN." How were COLLPLANT HOLDI/S's earnings last quarter? COLLPLANT HOLDI/S (NASDAQ:CLGN) announced its earnings results on Thursday, November, 29th. The company reported $0.29 earnings per share for the quarter. The firm had revenue of $0.22 million for the quarter. COLLPLANT HOLDI/S had a negative return on equity of 74.04% and a negative net margin of 435.47%. View COLLPLANT HOLDI/S's Earnings History. When is COLLPLANT HOLDI/S's next earnings date? COLLPLANT HOLDI/S is scheduled to release their next quarterly earnings announcement on Wednesday, March 20th 2019. View Earnings Estimates for COLLPLANT HOLDI/S. What price target have analysts set for CLGN? 1 analysts have issued twelve-month target prices for COLLPLANT HOLDI/S's shares. Their predictions range from $7.00 to $7.00. On average, they anticipate COLLPLANT HOLDI/S's stock price to reach $7.00 in the next year. This suggests a possible upside of 25.0% from the stock's current price. View Analyst Price Targets for COLLPLANT HOLDI/S. What is the consensus analysts' recommendation for COLLPLANT HOLDI/S? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for COLLPLANT HOLDI/S in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for COLLPLANT HOLDI/S. Has COLLPLANT HOLDI/S been receiving favorable news coverage? Press coverage about CLGN stock has trended somewhat positive on Saturday, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. COLLPLANT HOLDI/S earned a media sentiment score of 1.7 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the immediate future. Who are some of COLLPLANT HOLDI/S's key competitors? Some companies that are related to COLLPLANT HOLDI/S include Rewalk Robotics (RWLK), Bionik Laboratories (BNKL), Precision Therapeutics (AIPT), NanoVibronix (NAOV), Wound Management Technologies (WNDM), Histogenics (HSGX), Allied Healthcare Products (AHPI), Avitar (AVTI) and Halyard Health (HYH). What other stocks do shareholders of COLLPLANT HOLDI/S own? Based on aggregate information from My MarketBeat watchlists, some companies that other COLLPLANT HOLDI/S investors own include AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA), Eastside Distilling (EAST), Trade Desk (TTD), Yintech Investment (YIN), SM Energy (SM), ReneSola (SOL), Ampliphi Biosciences (APHB), Leucrotta Exploration (LXE) and Canopy Rivers (RIV). Who are COLLPLANT HOLDI/S's key executives? COLLPLANT HOLDI/S's management team includes the folowing people: Mr. Yehiel Tal, Chief Exec. Officer (Age 67)Prof. Oded Shoseyov, Founder & Chief Scientist Officer (Age 63)Mr. Eran Rotem, Deputy CEO & CFO (Age 51)Dr. Philippe David Bensimon, VP of Regulation Affairs & Quality Assurance (Age 54)Dr. Nadav Orr, VP of R&D (Age 62) When did COLLPLANT HOLDI/S IPO? (CLGN) raised $22 million in an initial public offering on Friday, December 9th 2016. The company issued 3,500,000 shares at $6.23 per share. Ladenburg Thalmann acted as the underwriter for the IPO and Roth Capital Partners was co-manager. How do I buy shares of COLLPLANT HOLDI/S? Shares of CLGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is COLLPLANT HOLDI/S's stock price today? One share of CLGN stock can currently be purchased for approximately $5.60. How big of a company is COLLPLANT HOLDI/S? COLLPLANT HOLDI/S has a market capitalization of $19.15 million and generates $480,000.00 in revenue each year. The company earns $-6,020,000.00 in net income (profit) each year or ($2.26) on an earnings per share basis. COLLPLANT HOLDI/S employs 29 workers across the globe. What is COLLPLANT HOLDI/S's official website? The official website for COLLPLANT HOLDI/S is http://www.collplant.com. How can I contact COLLPLANT HOLDI/S? COLLPLANT HOLDI/S's mailing address is 3 SAPIR ST. WEIZMANN SCIENCE PARK P.O.B. 4132, NESS-ZIONA L3, 74140. The company can be reached via phone at 972-73-232-5600 or via email at [email protected] MarketBeat Community Rating for COLLPLANT HOLDI/S (NASDAQ CLGN)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 58 (Vote Outperform)Underperform Votes: 81 (Vote Underperform)Total Votes: 139MarketBeat's community ratings are surveys of what our community members think about COLLPLANT HOLDI/S and other stocks. Vote "Outperform" if you believe CLGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLGN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/23/2019 by MarketBeat.com StaffFeatured Article: What is the downside to momentum investing?